| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.066 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |